hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
COA Verification Notice: Even if the vial label or product image states a certain concentration, always go by the COA for the true verified value
GLP-1 medications affect appetite and glucose metabolism but do not directly support liver function or energy production
5-Amino-1MQ is a small molecule that blocks that enzyme, which raises cellular NAD+ and, in research, helps fat cells shrink and burn energy again without changing your diet
It can be a little unpleasant, but it is over within less than a minute
Guide for the Care and Use of Laboratory Animals , 8th ed, 220 (National Academies Press, 2011)